195 related articles for article (PubMed ID: 12489282)
21. [British and American screening guidelines inadequate for prevention of colorectal carcinoma in patients with inflammatory bowel disease].
Vleggaar FP; Lutgens MW; Oldenburg B; Schipper ME; Samsom M
Ned Tijdschr Geneeskd; 2007 Dec; 151(50):2787-91. PubMed ID: 18232199
[TBL] [Abstract][Full Text] [Related]
22. Paradigm Shift in the Surveillance and Management of Dysplasia in Inflammatory Bowel Disease (West).
Soetikno R; Kaltenbach T; McQuaid KR; Subramanian V; Kumar R; Barkun AN; Laine L
Dig Endosc; 2016 Apr; 28(3):266-73. PubMed ID: 26866420
[TBL] [Abstract][Full Text] [Related]
23. [Chemoprevention of colorectal cancer in inflammatory bowel disease].
Han SH; Lee J
Korean J Gastroenterol; 2014 Jan; 63(1):3-10. PubMed ID: 24463282
[TBL] [Abstract][Full Text] [Related]
24. Molecular screening for colon cancer in inflammatory bowel disease.
Malcomson RD; McGregor AH
Eur J Gastroenterol Hepatol; 2002 Oct; 14(10):1045-7. PubMed ID: 12362091
[TBL] [Abstract][Full Text] [Related]
25. Chromoendoscopy for Surveillance in Inflammatory Bowel Disease Does Not Increase Neoplasia Detection Compared With Conventional Colonoscopy With Random Biopsies: Results From a Large Retrospective Study.
Mooiweer E; van der Meulen-de Jong AE; Ponsioen CY; Fidder HH; Siersema PD; Dekker E; Oldenburg B
Am J Gastroenterol; 2015 Jul; 110(7):1014-21. PubMed ID: 25823770
[TBL] [Abstract][Full Text] [Related]
26. Colorectal Cancer in Patients With Inflammatory Bowel Disease: The Need for a Real Surveillance Program.
Fornaro R; Caratto M; Caratto E; Caristo G; Fornaro F; Giovinazzo D; Sticchi C; Casaccia M; Andorno E
Clin Colorectal Cancer; 2016 Sep; 15(3):204-12. PubMed ID: 27083409
[TBL] [Abstract][Full Text] [Related]
27. Risk of colorectal high-grade dysplasia and cancer in a prospective observational cohort of patients with inflammatory bowel disease.
Beaugerie L; Svrcek M; Seksik P; Bouvier AM; Simon T; Allez M; Brixi H; Gornet JM; Altwegg R; Beau P; Duclos B; Bourreille A; Faivre J; Peyrin-Biroulet L; Fléjou JF; Carrat F;
Gastroenterology; 2013 Jul; 145(1):166-175.e8. PubMed ID: 23541909
[TBL] [Abstract][Full Text] [Related]
28. [Inflammatory bowel disease and colorectal cancer].
Hagymási K; Tulassay Z
Orv Hetil; 2006 Oct; 147(41):1977-82. PubMed ID: 17120688
[TBL] [Abstract][Full Text] [Related]
29. Should patients with Crohn's disease be in colonoscopic surveillance programs?
Lashner BA
Inflamm Bowel Dis; 2008 Oct; 14 Suppl 2():S192-3. PubMed ID: 18816656
[No Abstract] [Full Text] [Related]
30. Dysplasia and Cancer in Inflammatory Bowel Disease.
Huang LC; Merchea A
Surg Clin North Am; 2017 Jun; 97(3):627-639. PubMed ID: 28501251
[TBL] [Abstract][Full Text] [Related]
31. Colorectal cancer and inflammatory bowel disease: epidemiology, risk factors, mechanisms of carcinogenesis and prevention strategies.
Triantafillidis JK; Nasioulas G; Kosmidis PA
Anticancer Res; 2009 Jul; 29(7):2727-37. PubMed ID: 19596953
[TBL] [Abstract][Full Text] [Related]
32. Toward a consensus on endoscopic surveillance of patients with colonic inflammatory bowel disease.
Shergill AK; Farraye FA
Gastrointest Endosc Clin N Am; 2014 Jul; 24(3):469-81. PubMed ID: 24975537
[TBL] [Abstract][Full Text] [Related]
33. Clinical practice guideline. Diagnosis and prevention of colorectal cancer. 2018 Update.
Cubiella J; Marzo-Castillejo M; Mascort-Roca JJ; Amador-Romero FJ; Bellas-Beceiro B; Clofent-Vilaplana J; Carballal S; Ferrándiz-Santos J; Gimeno-García AZ; Jover R; Mangas-Sanjuán C; Moreira L; Pellisè M; Quintero E; Rodríguez-Camacho E; Vega-Villaamil P;
Gastroenterol Hepatol; 2018 Nov; 41(9):585-596. PubMed ID: 30245076
[TBL] [Abstract][Full Text] [Related]
34. Colon cancer in inflammatory bowel disease: recent trends, questions and answers.
Viennot S; Deleporte A; Moussata D; Nancey S; Flourié B; Reimund JM
Gastroenterol Clin Biol; 2009 Jun; 33 Suppl 3():S190-201. PubMed ID: 20117342
[TBL] [Abstract][Full Text] [Related]
35. Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease.
Mpofu C; Watson AJ; Rhodes JM
Cochrane Database Syst Rev; 2004; (2):CD000279. PubMed ID: 15106148
[TBL] [Abstract][Full Text] [Related]
36. Updates in colorectal cancer screening in inflammatory bowel disease.
Clarke WT; Feuerstein JD
Curr Opin Gastroenterol; 2018 Jul; 34(4):208-216. PubMed ID: 29771698
[TBL] [Abstract][Full Text] [Related]
37. Cancer in inflammatory bowel disease.
Bachwich DR; Lichtenstein GR; Traber PG
Med Clin North Am; 1994 Nov; 78(6):1399-412. PubMed ID: 7967916
[TBL] [Abstract][Full Text] [Related]
38. Reduction of colorectal cancer risk in patients with Crohn's disease.
Lichtenstein GR
Rev Gastroenterol Disord; 2002; 2 Suppl 2():S16-24. PubMed ID: 12478240
[TBL] [Abstract][Full Text] [Related]
39. Surveillance for cancer and dysplasia in inflammatory bowel disease.
Rubin DT; Kavitt RT
Gastroenterol Clin North Am; 2006 Sep; 35(3):581-604. PubMed ID: 16952742
[TBL] [Abstract][Full Text] [Related]
40. Nearly a Third of High-Grade Dysplasia and Colorectal Cancer Is Undetected in Patients with Inflammatory Bowel Disease.
Eluri S; Parian AM; Limketkai BN; Ha CY; Brant SR; Dudley-Brown S; Efron JE; Fang SG; Gearhart SL; Marohn MR; Meltzer SJ; Bashar S; Truta B; Montgomery EA; Lazarev MG
Dig Dis Sci; 2017 Dec; 62(12):3586-3593. PubMed ID: 28631086
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
